Kahn Clare 4
4 · Solid Biosciences Inc. · Filed Jun 13, 2025
Insider Transaction Report
Form 4
Kahn Clare
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2025-06-12+77,500→ 77,500 totalExercise: $4.58Exp: 2035-06-12→ Common Stock (77,500 underlying)
Footnotes (1)
- [F1]This option was granted on June 12, 2025 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.